The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

Select your location to view local American Lung Association events and news near you.

The rise of GLP-1s prescribed for weight loss and type 2 diabetes is leading to potentially misleading patterns in cancer scans.

GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...

• The present study revealed a statistically significant increase in the maximum standardized uptake value and the tumor-to-background ratio of fluorine 18-labeled fibroblast activation protein ...

The goal of this investigation was to compare the diagnostic performance of radial T1-weighted gradient-echo (radial volumetric interpolated breath-hold examination [VIBE]) MRI, PET, simultaneous ...

Staging locally advanced breast cancer patients with 18 F-labeled fluorodeoxyglucose (FDG) PET-CT detected more distant metastases -- and thus reduced the number of patients who received combined ...